Addiction Cure Therapeutic Sciences
Early Stage
Advancing First-in-Class Therapeutics
Overview
Raised: $0
Total Commitments ($USD)
Platform
Netcapital
Start Date
09/11/2022
Close Date
04/03/2023
Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment
$99
Security Type
Equity - Common
Series
Pre-Seed
SEC Filing Type
RegCF
Price Per Share
$0.50
Pre-Money Valuation
$6,051,000
Rolling Commitments ($USD)
Status
Not Funded
Reporting Date
04/08/2023
Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise
$0
Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2020
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
Addiction Cure Therapeutic Sciences, with a valuation of $6.05 million, is raising funds on NetCapital. It is a biotech firm aiming to treat and cure drug and alcohol addiction. The company is using a unique approach to cure addiction through erasing epigenetic bookmarks and rearranging them to support new behavior. The scientists at Addiction Cure Therapeutic Sciences are exploring the underlying epigenetic causes of addiction and targeting them for treatment. Jack Levine founded Addiction Cure Therapeutic Sciences in April 2020. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,070,000. The campaign proceeds will be used for lab compound testing, research and development, salaries, marketing, and trade shows.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-2,716 |
$-10,002 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$1,013 |
$0 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$1,013 |
$0 |
|
Short-Term Debt |
$3,729 |
$150 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$3,729 |
$150 |
Financials as of: 09/11/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.